Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:20 PM ET Form 4
Insider Selling Pinnacle Financial Partners, Inc. PNFP

Pinnacle Financial Partners CLO Allan E. Kamensky Sells $523K of Stock

Allan E. Kamensky, CLO, sold 5,000 shares of Pinnacle Financial Partners, Inc. at $104.62 a share, worth $523K in total on Nov 2, 2026. Shares held after the trade: 43,940 (-10.2%).

Value
$523K
Shares
5,000
Price
$104.62
Role
CLO
Holding change
-10.2%
Trade date
Nov 2, 2026
4:20 PM ET 10-Q
Financial Results Aquestive Therapeutics, Inc. AQST

Aquestive Therapeutics Q3 2026 Results: Net Loss of $16.5M, Loss Widens

Aquestive Therapeutics reported a net loss of $47.4 million for the nine months ended September 30, 2026, compared to a loss of $54.9 million in the prior year period. Total revenues increased to $35.8 million from $31.5 million, while the company recognized a $11.7 million loss on the extinguishment of debt following the redemption of its 13.5% Notes.

Key figure
Net loss $16.5M
4:20 PM ET 8-K
Financial Results Eastman Kodak Co KODK

Eastman Kodak Financial Results

Eastman Kodak reported third-quarter 2026 financial results with consolidated revenue of $276 million, a 3% increase year-over-year driven by 21% growth in its Advanced Materials & Chemicals (AM&C) segment. The company achieved GAAP net income of $21 million and generated $27 million in cash during the quarter, ending the period with a cash balance of $317 million.

Term
Q3 2026

“Kodak delivered strong performance in the third quarter, once again achieving year-over-year improvement in revenue, gross profit and Operational EBITDA. We continue to execute our long-term plan and are seeing a return on our ongoing investments. Our primary growth engine, AM&C, is now our fastest growing, most profitable unit. Our print business has performed well for the year to date despite challenging economic conditions. And, most importantly, we generated $27 million in cash for Q3, an important indicator of the operational strength of our business. Looking forward, we’re focused on continuing to invest in our core businesses and finishing the year with profitable growth.”

Jim Continenza, Kodak’s Executive Chairman and CEO
4:20 PM ET 8-K
Leadership Change Pfizer Inc PFE

Pfizer Leadership Change

Pfizer Inc. has appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Ms. Guegan, who had been serving as Interim CFO since August 2026, will receive an annual base salary of $1.3 million and a target cash incentive opportunity of 100% of her base salary.

4:20 PM ET 10-Q
Financial Results Coupang, Inc. CPNG

Coupang Q3 2026 Results: Net Loss of $501M

Coupang, Inc. filed its Q3 2026 Form 10-Q reporting on the quarterly period ended September 30, 2026. The filing highlights the company's status as a large accelerated filer and details its share structure, consisting of approximately 1.63 billion Class A and 157.8 million Class B shares. Key focus areas include growth strategies in retail, expansion into new geographies, and managing macroeconomic risks such as inflationary pressures and foreign currency fluctuations.

Key figure
Net loss $501M
4:19 PM ET 8-K
Financial Results United Fire Group Inc UFCS

United Fire Group Financial Results

United Fire Group reported Q3 2026 net income of $35.1 million, a 10% decrease from the prior year, despite a 13% increase in net written premiums to $371.4 million. The company achieved a combined ratio of 94.6% and reported record year-to-date earnings with a 14.0% return on equity.

Term
Q3 2026

“UFG delivered its strongest quarter of 2026, contributing to an exceptional first nine months of the year. The quarter's overall performance reflects the quality of the portfolio we have built by deepening our underwriting expertise, strengthening our distribution partnerships, expanding our capabilities and improving operational effectiveness.”

Kevin Leidwinger, President and CEO

“Through the first nine months of 2026, we generated record earnings, achieved a 14.0% return on equity and produced a 95.2% combined ratio.”

Kevin Leidwinger, President and CEO
4:19 PM ET 8-K
Financial Results Jackson Financial Inc. JXN

Jackson Financial Financial Results

Jackson Financial reported record retail annuity sales of $6.5 billion and net income of $847 million for the third quarter of 2026. The company achieved adjusted operating earnings of $7.55 per diluted share and returned $291 million to shareholders through dividends and buybacks. Additionally, the Board approved a $1 billion increase to the company's share repurchase authorization.

Term
Q3 2026

“Our third quarter results reflect the strength of our business and consistent execution against our strategy. We grew adjusted operating earnings per share, while delivering record retail annuity sales, up 22% year over year. Our distribution reach will be further enhanced by our recent announcement that Jackson has been named the exclusive provider of annuities for AARP members through the AARP® Annuity Program from Jackson®.”

Don Cummings, Chief Executive Officer and President of Jackson
4:19 PM ET 10-Q
Financial Results Eastman Kodak Co KODK

Eastman Kodak Q3 2026 Results: Net Income $21M, Up 61.5% YoY

Eastman Kodak reported a net income of $21 million for the quarter ended September 30, 2026, compared to $13 million in the prior year period. Total revenues increased to $276 million from $269 million, while the company significantly reduced its long-term debt from $208 million at the end of 2025 to $108 million.

Key figure
Net income $21M · +61.5% YoY
4:19 PM ET 8-K
Financial Results First Tracks Biotherapeutics, Inc. TRAX

First Tracks Biotherapeutics Financial Results

First Tracks Biotherapeutics reported Q3 2026 financial results, highlighting a pro forma cash position of $343 million following a $200 million private placement. The company reported positive Phase 1b data for its lead candidate ANB033 in celiac disease and plans to initiate late-stage clinical development in 2027.

“ANB033, a subcutaneously administered CD122 antagonist designed to inhibit signaling of both IL-15 and IL-2 on immune cells, demonstrated statistically significant protection against gluten-induced intestinal damage and symptoms and was well tolerated in the Phase 1b gluten-challenge cohort. These data support our plans to progress ANB033 into late-stage development in 2027 in celiac disease as a potential treatment to prevent both acute symptoms and intestinal damage from gluten exposure despite general adherence to a gluten-free diet.”

Daniel Faga, president and chief executive officer
4:19 PM ET 8-K
Financial Results Alight, Inc. ALIT

Alight Financial Results

Alight, Inc. reported third quarter 2026 revenue of $500 million, a 6.2% decrease year-over-year, and a net loss of $51 million. Despite the revenue decline, the company raised its full-year 2026 business outlook for revenue and Adjusted EBITDA, citing improved retention metrics and transformation initiatives.

Term
Q3 2026

“We are pleased to have surpassed revenue and adjusted EBITDA expectations for the third consecutive quarter, reflecting our continued execution of our long-term strategy to bolster Alight’s leadership position in the market and return to positive commercial momentum.”

Rohit Verma, Chief Executive Officer of Alight

“Our demonstrated progress with our transformation initiatives has enabled us to win several new logos and expand our relationships with existing clients. We also expanded account coverage to relationships which represent over 95% of recurring revenue.”

Rohit Verma, Chief Executive Officer of Alight
4:19 PM ET 10-Q
Financial Results Ibotta, Inc. IBTA

Ibotta Q3 2026 Results: Net Loss of $3.5M

Ibotta, Inc. reported total assets of $494.1 million as of September 30, 2026, a decrease from $525.9 million at the end of 2025, primarily driven by a reduction in cash and cash equivalents. The company maintains a dual-class stock structure with 20,469,814 shares of Class A and 2,962,664 shares of Class B common stock outstanding as of October 31, 2026.

Key figure
Net loss $3.5M
4:19 PM ET 8-K
Financial Results LendingTree, Inc. TREE

LendingTree Financial Results

LendingTree reported Q3 2026 revenue of $343.6 million, a 12% year-over-year increase driven by growth across its Insurance, Consumer, and Home segments. The company reported a GAAP net loss of $72.4 million primarily due to a $98.8 million non-cash goodwill impairment charge. Management announced plans to resume share repurchases in Q4 2026 and highlighted the voluntary repayment of $60 million in long-term debt during the quarter.

Term
3 months

“We are pleased to report our tenth straight quarter of double-digit revenue growth, powered by continued strength in our Insurance segment along with healthy growth in Home driven by great home equity lending results.”

Scott Peyree, CEO

“The company is on track to grow revenue and AEBITDA this year by 17% and 14%, respectively, at the midpoint of our updated forecast. Our business benefits from the diversity of our product offering for consumers, providing one unified marketplace for all personal financial products.”

Jason Bengel, CFO
4:19 PM ET 10-Q
Financial Results Janus Living, Inc. JAN ▶ Call

Janus Living Q3 2026 Results: Net Loss of $4.32M

Janus Living, Inc. reported a net loss of $5.6 million for the third quarter of 2026, despite a significant revenue increase to $268.3 million following its initial public offering and real estate acquisitions. The company's balance sheet expanded significantly, with total assets growing from $2.3 billion to $5.2 billion during the first nine months of the year.

Key figure
Net loss $4.32M
4:18 PM ET 8-K
Leadership Change Macrogenics Inc MGNX

Macrogenics Leadership Change

MacroGenics appointed Dr. Michael Vasconcelles and Dr. Emil Kuriakose to its Board of Directors, effective October 30, 2026, increasing the board size to eleven members. Both appointees are independent directors with extensive oncology drug development experience and will serve on the company's Science and Technology Committee.

4:18 PM ET 10-Q
Financial Results Angel Oak Mortgage REIT, Inc. AOMR

Angel Oak Mortgage REIT Q3 2026 Results: Net Loss of $16.7M

Angel Oak Mortgage REIT reported a net loss of $16.7 million for the quarter ended September 30, 2026, primarily driven by $20.9 million in net realized and unrealized losses. Total assets grew to $2.9 billion, supported by an increase in residential mortgage loans held in securitization trusts, while stockholders' equity decreased to $209.8 million.

Key figure
Net loss $16.7M
4:18 PM ET 8-K
Financial Results Andersons, Inc. ANDE

Andersons Financial Results

The Andersons, Inc. reported record third quarter 2026 net income of $46 million, or $1.36 per diluted share, driven by strong performance in its Renewables and Agribusiness segments. The company highlighted $27 million in 45Z tax credits from low-carbon strategies and noted that its Houston soybean meal export project is now operational.

Term
Q3 2026

“Our third quarter results reflect significant year-over-year improvement in both Renewables and Agribusiness. Renewables delivered strong quarterly results from our production assets with operational execution, higher co-product values, and lower eastern corn basis. Ethanol and corn-oil yields improved year-over-year. In the quarter, we recognized $27 million of 45Z tax credits as a result of our low-carbon strategies.”

Bill Krueger, President and CEO

“Agribusiness delivered improvement over last year with the merchandising businesses executing on market opportunities. This resulted from higher commodity prices and increased volatility, primarily from western grain belt weather variability and production uncertainty during the quarter. We expect market dislocations and a solid eastern grain belt harvest to provide opportunities in the fourth quarter and into 2027”

Bill Krueger, President and CEO
4:18 PM ET 10-Q
Financial Results Jpmorgan Chase & Co JPM

Jpmorgan Chase & Q3 2026 Results: Net Income $15.3B, Up 6.3% YoY

JPMorgan Chase reported net income of $15.3 billion for the third quarter of 2026, with a return on tangible common equity of 20%. Total assets grew to over $5.09 trillion, while the firm maintained a strong CET1 capital ratio of 14.0%. Results for the first nine months of 2026 were bolstered by a $4.6 billion net gain related to Visa shares recorded in the second quarter.

Key figure
Net income $15.3B · +6.3% YoY
4:18 PM ET 10-Q
Financial Results Transocean Ltd. RIG

Transocean Q3 2026 Results: Turns Profitable, Net Income $26M

Transocean Ltd. reported a net income of $26 million for the third quarter of 2026, a significant recovery from a $1.92 billion loss in the prior year period which was impacted by heavy asset impairments. For the nine months ended September 30, 2026, the company generated $574 million in operating cash flow and reduced its long-term debt to $4.56 billion.

Key figure
Net income $26M
4:18 PM ET 8-K
Dividend TXO Partners, L.P. TXO

TXO Partners Dividend

TXO Partners, L.P. declared a quarterly cash distribution of $0.44 per common unit for the third quarter of 2026. The distribution is payable on November 20, 2026, to unitholders of record as of November 13, 2026. The company also posted an updated investor presentation to its website.

Term
Q3 2026
4:18 PM ET Form 4
Insider Selling National Bank Holdings Corp NBHC

National Bank Holdings Director Art Zeile Sells $150K of Stock

Art Zeile, Director, sold 4,000 shares of National Bank Holdings Corp at $37.43 a share, worth $150K in total on Oct 30, 2026. Shares held after the trade: 15,816 (-20.2%).

Value
$150K
Shares
4,000
Price
$37.43
Role
Director
Holding change
-20.2%
Trade date
Oct 30, 2026
4:18 PM ET 10-Q
Financial Results Healthpeak Properties, Inc. DOC ▶ Call

Healthpeak Properties Q3 2026 Results: Turns Profitable, Net Income $17.3M

Healthpeak Properties reported total revenues of $820.9 million for the third quarter of 2026, up from $705.9 million in the prior year, driven by a significant increase in resident fees and services. Net income attributable to the company was $17.3 million ($0.02 per share), a recovery from a net loss of $117.1 million in the same period of 2025.

Key figure
Net income $17.3M
4:18 PM ET 8-K
Financial Results Community Healthcare Trust Inc CHCT

Community Healthcare Trust Financial Results

Community Healthcare Trust reported Q3 2026 net income of $3.1 million and total revenue growth of 4% sequentially, reflecting progress on its strategic plan. The company declared a quarterly dividend of $0.33 per share and noted it has $99.0 million in properties under definitive purchase agreements expected to close between late 2026 and early 2028.

Term
Q3 2026
4:18 PM ET 8-K
Investor Presentation Jackson Financial Inc. JXN

Jackson Financial Investor Presentation

Jackson Financial Inc. has prepared a slide presentation to accompany its third quarter 2026 earnings call scheduled for November 4, 2026. The presentation, furnished as Exhibit 99.1, provides financial highlights and non-GAAP metrics for the period ended September 30, 2026.

4:17 PM ET 10-Q
Financial Results Columbus Mckinnon Corp CMCO

Columbus Mckinnon Q2 2026 Results: Net Loss of $25.5M

Columbus McKinnon reported total assets of $4.68 billion as of September 30, 2026, with a significant portion of its capital structure consisting of $2.26 billion in long-term debt and $818.4 million in preferred stock. The company is currently integrating the Kito Crosby Acquisition and managing a transition following the divestiture of its legacy U.S. power chain hoist operations.

Key figure
Net loss $25.5M
4:17 PM ET 8-K
Financial Results Comscore, Inc. SCOR

Comscore Financial Results

Comscore reported third quarter 2026 revenue of $76.2 million, a 14.3% decrease year-over-year, and a net loss of $65.5 million primarily driven by a $57.3 million non-cash goodwill impairment charge. The company is executing a transformational ROI strategy to realign its cost structure and reaffirmed its full-year 2026 revenue guidance.

Term
Q3 2026

“During the third quarter, we announced our transformational ROI strategy, which was designed to realign our business and cost structure, optimize our operations, and invest in higher-potential growth areas. Our team executed against this new operating model with a strong sense of urgency, allowing us to achieve significant cost savings in the quarter.”

Matt McLaughlin, Chief Executive Officer of Comscore

“We are taking aggressive actions to rationalize our operational footprint and are focused on serving customers in our core business, as well as identifying and capitalizing on long-term growth opportunities in the evolving media landscape. I'm proud of the difficult work our team has done to execute against our plan and remain confident that we will exit the year well positioned to transform the business in 2027 and begin investing for long-term growth.”

Matt McLaughlin, Chief Executive Officer of Comscore
4:17 PM ET Form 4
Insider Selling Masco Corp MAS

Masco VP, General Counsel and Sec. Kenneth G. Cole Sells $2.78M of Stock

Kenneth G. Cole, VP, General Counsel and Sec., sold 34,470 shares of Masco Corp at $80.64 a share, worth $2.78M in total on Oct 30, 2026. Shares held after the trade: 39,700 (-46.5%).

Value
$2.78M
Shares
34,470
Price
$80.64
Role
VP, General Counsel and Sec.
Holding change
-46.5%
Trade date
Oct 30, 2026
4:17 PM ET 8-K
Financial Results Redwood Trust Inc RWT

Redwood Trust Financial Results

Redwood Trust reported third-quarter 2026 financial results, highlighted by a 26% annualized return on capital in its mortgage banking platforms and a strategic plan to transition to a C-corporation in 2027. The company reported a GAAP net loss of $0.39 per share, primarily driven by fair value changes in its legacy investment segment as it accelerates the resolution of those assets.

Term
Q3 2026
4:17 PM ET Form 4
Insider Selling Icon PLC ICLR

Icon CAO Emer Lyons Sells $53.7K of Stock

Emer Lyons, CAO, sold 260 shares of Icon PLC at $204.91 to $208.00 a share (average $206.61) in 4 transactions, worth $53.7K in total on Nov 2, 2026. Shares held after the trade: 1,221 (-5.2%).

Value
$53.7K
Shares
260
Average price
$206.61
Role
CAO
Holding change
-5.2%
Trade date
Nov 2, 2026
4:17 PM ET 10-Q
Financial Results Pacs Group, Inc. PACS ▶ Call

Pacs Group Q3 2026 Results: Net Income $60.8M, Up 16.1% YoY

PACS Group, Inc. reported total assets of $5.9 billion as of September 30, 2026, with 158,723,533 shares of common stock outstanding. The company is classified as an accelerated filer and an emerging growth company, operating primarily in the healthcare facility sector with significant geographic concentration in California.

Key figure
Net income $60.8M · +16.1% YoY
4:17 PM ET 10-Q
Financial Results Block, Inc. XYZ

Block Q3 2026 Results: Net Income $566M, Up 22.5% YoY

For the quarter ended September 30, 2026, Block, Inc. reported total net revenue of $6.72 billion and net income attributable to common stockholders of $565.6 million. Gross profit grew to $3.24 billion, though operating expenses increased significantly to $2.81 billion, driven by higher general and administrative costs and credit losses.

Key figure
Net income $566M · +22.5% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.